First Patient Dosed for MRCT Phase 3 Study on First-Line LS-SCLC of Henlius Anti-PD-1 mAb Serplulimab in Europe
SHANGHAI, Oct. 25, 2023 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the first patient in Europe has been dosed in the international multi-centre phase 3 clinical trial (NCT05353257) of the company's self-developed anti-PD-1 mAb HANSIZHUANG (serplulimab) in combination with chemotherapy and concurrent radiotherapy in patients with limited-stage small cell lung cancer (LS-SCLC) in EU country Latvia. The co-leading principal...
Altair to Showcase Pharmaceutical Process Optimization Technology at the Korea Pharm&Bio 2023
Altair will feature pharmaceutical manufacturing process simulation and data analytics technologies SEONGNAM, South Korea, April 13, 2023 /PRNewswire/ -- Altair (Nasdaq: ALTR), a global leader in computational science and artificial intelligence (AI), will be exhibiting at Korea Pharm&Bio, April 18-21 in Goyang City, Gyeonggi-do, South Korea. At the event, Altair will showcase technologies...
Henlius’ anti-PD-1 mAb MRCT achieved 15.38 months OS in first-line treatment of SCLC, reducing the risk of death by 38% of the overall population
The ASTRUM-005 states that serplulimab combined with carboplatin-etoposide prolonged median OS in both the overall population and the Asian subgroup, the median overall survival (OS) in the serplulimab and placebo groups were 15.38 and 11.10 months, respectively, reducing risk of death by 38% (41% in the Asian subgroup), p <0.001. The 2-year OS rate (OSR) in the two...
WeTrade Group Inc. Announces US$50 Million Sales of Monkeypox Virus Test Kits to Parkway Medical Limited
BEIJING, Aug. 12, 2022 /PRNewswire/ -- WeTrade Group Inc. ("Wetrade" or the "Company") (NASDAQ: WETG), an emerging growth company engaged in the business of providing software-as-a-services (SAAS) and cloud intelligent systems for micro-businesses, today announced the Company has entered into a sales agreement (the "Agreement") on August 11, 2022 with Parkway Medical Limited ("Parkway Medical") to sell monkeypox virus...
Frost & Sullivan grants the Global Biologics CDMO Technology Leadership Award to BiBo Pharma
SHANGHAI, Sept. 9, 2024 /PRNewswire/ -- Frost & Sullivan is pleased to announce that the 18th Growth Innovation Leadership (GIL) Summit and the 3rd New Investment Event (NIE 2024), was held in Shanghai from August 27 to 30, 2024, co-hosted by LeadLeo. Based on research and analysis of the global CDMO market, as well as studies and evaluations of...
NCCN Commits to Sharing Award-Winning Resources for People with Cancer in Spanish and Other Languages
Translations are underway for the entire library of NCCN Guidelines for Patients to empower people with cancer and caregivers worldwide to make informed treatment decisions that are best for them. PLYMOUTH MEETING, Pa., Sept. 12, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—and the NCCN Foundation®...
Siriraj Hospital Integrates AI to Elevate Medical Research and Diagnosis, Touts YOLO Model for Centroblast Cell Counting
BANGKOK, Aug. 5, 2024 /PRNewswire/ -- The Faculty of Medicine Siriraj Hospital at Mahidol University has announced the integration of artificial intelligence (AI) technology to improve medical analysis and diagnostic capabilities. This initiative aims to enhance accuracy in detecting abnormalities, diagnosing diseases, and optimizing the workflow of medical personnel. Siriraj Hospital Integrates AI to Elevate...
The China NMPA Approved CYRAMZA® (ramucirumab) for the Treatment in Patients with Hepatocellular Carcinoma
ROCKVILLE, Md. and SUZHOU, China, Oct. 10, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and other major diseases, is pleased to see that the National Medical Products Administration (NMPA) of China has approved the supplemental New Drug Application (sNDA)...
United Imaging Flips the Script on its Events Program for 2022, Reveals Expanded Sales Force and U.S. Growth
Its new AE also trains new salespeople on the company's unique take on medical imaging purchasing. HOUSTON, May 3, 2022 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, said that it has enhanced its U.S. domestic events program in 2022 as it also welcomed a new class of sales hires to meet growing customer demand. United Imaging revealed significant growth, just three and a half years...
Bupa Hong Kong has selected Cognizant to deliver an AI-driven BPaaS solution to transform health insurance claims
Strategic collaboration aims to enhance operational efficiency and mitigate risks by transitioning to a business process more aligned with regulatory requirements HONG KONG, Dec. 18, 2025 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) today announced a strategic collaboration with Bupa Hong Kong, a leading health insurance specialist in Hong Kong, to deliver Cognizant's first AI-driven Business-Process-as-a-Service...
